EU Clinical Trials Register: useless? [Regulatives / Guidelines]

posted by Ohlbe – France, 2018-01-23 18:54 (2669 d 11:57 ago) – Posting: # 18280
Views: 9,161

Dear Helmut,

❝ #3: 12.8% of studies were inspected? Wow! Given that some studies with an assigned EudraCT number were never performed, the percentage is higher.


No. In a Phase 3 study they may have inspected several clinical sites, the sponsor, a central lab, a CRO... And several Member States may inspect the same trial. So I would expect the figure to be much lower.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
170 visitors (0 registered, 170 guests [including 14 identified bots]).
Forum time: 07:51 CEST (Europe/Vienna)

A statistical analysis, properly conducted, is a delicate dissection of
uncertainties, a surgery of suppositions.    Micheal J. Moroney

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5